Immatics N.V. (NASDAQ:IMTX) Is a Favorite Amongst Institutional Investors Who Own 50%

Yahoo FinanceOct 23 07:11 ET

Perceptive Advisors LLC Reduces Stake in Immatics NV

Yahoo FinanceOct 17 19:02 ET

6-K: Report of foreign private issuer (related to financial reporting)

SECOct 15 16:15 ET · Announcements

Buy Rating Affirmed for Immatics Amidst Promising Clinical Trials and Strategic Positioning in TCR Therapeutics

TipRanksOct 15 02:45 ET · Ratings

More Unpleasant Surprises Could Be In Store For Immatics N.V.'s (NASDAQ:IMTX) Shares After Tumbling 26%

Simply Wall StOct 13 08:35 ET

Express News | Immatics NV : Leerink Partners Cuts Target Price to $19 From $21

ReutersOct 11 10:24 ET